SMP30 has shown antitumor activity [5], and the development of SMP30 gene expression has been associated with preventive effects against the progression of cancer cells—SMP30 can reduce the progression of carcinogens and be useful in cancer treatment [6,7], and the expression of SMP30 in cancer cells is higher compared to normal tissue [8]. This evidence concerns the gene RGN and cancer.